NCT07529717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07529717
Title First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer (CRIUS-1)
Acronym CRIUS-1
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site RECRUITING Orlando Florida 32806 United States Details
Research Site NOT_YET_RECRUITING East Brunswick New Jersey 08816 United States Details
Research Site NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Research Site NOT_YET_RECRUITING Providence Rhode Island 02903 United States Details
Research Site NOT_YET_RECRUITING Darlinghurst 2010 Australia Details
Research Site RECRUITING Melbourne 3000 Australia Details
Research Site RECRUITING Seoul 03722 South Korea Details
Research Site RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field